The stock market is constantly changing and today, there are a few key factors driving the market. In the mid cap index, we have seen some changes in technical calls for certain stocks. Ajanta Pharma has been upgraded from a hold to a buy, while IDFC First Bank has also been upgraded from a hold to a buy. Looking at the advance decline ratio in this mid cap segment, we can see that 43 stocks are advancing while 79 stocks are declining, with a ratio of 0.54x. This indicates that there is a mix of both positive and negative movement in the market. Investors should also keep an eye on the upcoming results of some major companies in this segment. Rajesh Exports, Muthoot Finance, Aditya Birla Fashion, Ipca Labs, and NMDC are all set to declare their results on 14th February 2024. In terms of stock scores, we have seen some upgrades in this mid cap segment. Sona BLW Precision, Astral, Aditya Birla Fashion, Endurance Tech, and Gillette India have all been upgraded from mildly bearish or sideways to mildly bullish. Looking at the overall performance of mid cap stocks, we can see that the BSE mid cap index is down by -0.05% today and has also seen a decline of -3.39% in the last 5 days. However, there are still some top performers in this segment, with IRFC showing a return of 5.08%. On the other hand, Glaxosmithkline Pharma has been the worst performer with a return of -7.10%. Investors should keep a close watch on these market trends and make informed decisions when it comes to their investments. With some stocks showing positive movement and others facing challenges, it is important to stay updated and make strategic moves in the market.